Categories Earnings, Health Care

Amicus Therapeutics (FOLD): Q3 2019 Earnings Snapshot

Earnings Update by AlphaStreet

— Amicus Therapeutics (NASDAQ: FOLD) reported Q3 2019 loss of $0.24 per share, vs. a loss of $0.32 expected.

— Revenues grew 137% to $48.8 million, vs. $47.6 million expected.

— Global revenue for Galafold was $48.8 million.

— FY19 Galafold revenue is expected to be $170 million to $180 million.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Salesforce stock hit by weak guidance, co-CEO’s exit. What next?

For technology stocks, 2022 has been a challenging year, with companies losing significant market value amid prolonged stock selloff. In that respect, Salesforce, Inc. (NYSE: CRM) is among the worst-affected

Macy’s (M): Here’s a look at the retailer’s expectations for the near term

Shares of Macy’s Inc. (NYSE: M) were down on Thursday. The stock has gained 36% over the past three months and 18% over the past one month. The company’s sales

KR Earnings: Kroger Q3 sales, profit increase and top expectations

Department store chain The Kroger Co. (NYSE: KR) on Thursday said its third-quarter sales and adjusted earnings increased year-over-year. The latest numbers also exceeded the market's expectations. Net earnings attributable to

Add Comment
Viewing Highlight